Curis (CRIS) Other Non Operating Income (2010 - 2021)
Curis (CRIS) reported Other Non Operating Income of $890000.0 for Q2 2021, up 88900.0% on a YoY basis from N/an in Q2 2020, and up 88900.0% quarter-over-quarter from $1000.0 in Q2 2020.
Curis (CRIS) Other Non Operating Income (2010 - 2021) Analysis & Trends
Curis has reported Other Non Operating Income for 10 years, with the latest figure at $890000.0 in Q2 2021.
- For the quarter ending Q2 2021, Other Non Operating Income rose 88900.0% year-over-year to $890000.0; the trailing twelve-month figure through Jun 2022 stood at $890000.0 (changed 0.0% YoY), and the FY2021 full-year result was $890000.0, up 3945.45% from the prior year.
- Other Non Operating Income for Q2 2021 stood at $890000.0, up from $1000.0 in the prior quarter.
- The five-year high for Other Non Operating Income was $890000.0 in Q2 2021, with the low at -$986000.0 in Q3 2017.
- Historically, Other Non Operating Income has averaged -$344500.0 across 5 years, with a median of -$353000.0 in 2017.
- Annual changes were most pronounced in 2017 — Other Non Operating Income slumped 77.34% — and 2021, when it surged 88900.0%.
- Curis' Other Non Operating Income stood at -$900000.0 in 2017, then gained by 10.67% to -$804000.0 in 2018, then surged by 102.49% to $20000.0 in 2019, then tumbled by 95.0% to $1000.0 in 2020, then surged by 88900.0% to $890000.0 in 2021.
- The last three Other Non Operating Income figures came in at $890000.0 (Q2 2021), $1000.0 (Q2 2020), and $21000.0 (Q1 2020), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 788,338.31 Bn | 788,338.28 Bn | - |
| 2 | Belite Bio | 56,560.00 Bn | 56,560.00 Bn | - |
| 3 | Quantum Biopharma | 17,329.30 Bn | 17,329.30 Bn | - |
| 4 | Legend Biotech | 3,341.00 Bn | 3,340.71 Bn | 242.10 Mn |
| 5 | Akari Therapeutics | 1,727.91 Bn | 1,727.91 Bn | - |
| 6 | Evaxion A | 1,536.68 Bn | 1,536.67 Bn | - |
| 7 | Psyence Biomedical | 238.34 Bn | 238.33 Bn | - |
| 8 | Vertex Pharmaceuticals | 113.42 Bn | 106.17 Bn | 2.59 Bn |
| 9 | Abivax | 95.45 Bn | 95.45 Bn | - |
| 10 | Curis | 8.58 Mn | -6.42 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2021 | 890,000.00 |
| Jun 30, 2020 | 1,000.00 |
| Mar 31, 2020 | 21,000.00 |
| Sep 30, 2019 | 20,000.00 |
| Mar 31, 2019 | -17,000.00 |
| Jun 30, 2018 | -804,000.00 |
| Dec 31, 2017 | -900,000.00 |
| Sep 30, 2017 | -986,000.00 |
| Jun 30, 2017 | -981,000.00 |
| Mar 31, 2017 | -689,000.00 |
| Dec 31, 2016 | -571,000.00 |
| Sep 30, 2016 | -556,000.00 |
| Jun 30, 2016 | -610,000.00 |
| Mar 31, 2016 | -635,000.00 |
| Dec 31, 2015 | -215,000.00 |
| Sep 30, 2015 | -699,000.00 |
| Jun 30, 2015 | -759,000.00 |
| Mar 31, 2015 | -826,674.00 |
| Dec 31, 2014 | -878,297.00 |
| Sep 30, 2014 | -827,112.00 |